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Abstract 
Hydra actinoporin-like toxin-1 (HALT-1) is a 20.8 kDa pore-forming toxin isolated from Hydra 
magnipapillata. HALT-1 shares structural similarity with actinoporins, a family that is well 
known for its haemolytic and cytolytic activity. However, the precise pore-forming mechanism 
of HALT-1 remains an open question since little is known about the specific target binding for 
HALT-1. For this reason, a comprehensive proteomic analysis was performed using affinity 
purification and SILAC-based mass spectrometry to identify potential protein-protein 
interactions between mammalian HeLa cell surface proteins and HALT-1. A total of 4 
mammalian proteins was identified, of which only folate receptor alpha was further verified by 
ELISA. Our preliminary results highlight an alternative-binding mode of HALT-1 to the human 
plasma membrane. This is the first evidence showing that HALT-1, an actinoporin-like protein, 
binds to a membrane protein, the folate receptor alpha. This study would advance our 
understanding of the molecular basis of toxicity of pore-forming toxins and provide new insights 
in the production of more potent inhibitors for the toxin-membrane receptor interactions.  
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1. Introduction 
 
Pore-forming toxins (PFTs) are characterized by their unique ability to form pores in 
the cell membrane.  They are produced by a variety of organisms such as bacteria (Geny and 
Popoff, 2006), yeast-fungi (Bussey, 1991) and human (Voskoboinik et al., 2010). In sea 
anemones, a group of alpha helical-pore-forming toxins (α-PFTs) was isolated and named 
actinoporins (Ferlan and Lebez, 1974; Kem, 1988; Turk, 1991). This group of toxins has 
characteristic features of PFTs, including small protein size of 18-20 kDa, an isoelectric point 
above 9, lack of cysteine residues and sphingomyelin dependence for membrane binding 
(Anderluh and Maček 2003; Norton 2009). The most studied members of the actinoporin family 
are equinatoxin II (EqtII) of Actinia equina and sticholysin II (StnII) of Stichodactyla helianthus 
(Šuput 2014; Rojko et al. 2016).  
After the first actinoporin was identified in Actinia equina, many other actinoporin-
like proteins were identified in other cnidarians. For example, six Hydra actinoporin-like toxins 
(HALTs) were identified in the genome of Hydra magnipapillata (Glasser et al. 2014). The 
amino acid sequences of these toxins share 30% identity with those of actinoporins from sea 
anemones (Glasser et al. 2014). In addition, HALT-1 showed haemolytic and cytolytic activity 
towards red blood cells and HeLa cells (Glasser et al. 2014; Liew et al. 2015). HALT-1 has a 
conserved cluster of aromatic amino acids and an amphiphilic N-terminus, which are proposed to 
play important roles in membrane binding and pore formation, respectively (Liew et al. 2015). 
Although HALT-1 is structurally similar to other actinoporins, a recent study showed that this 
toxin produced a different pore size from EqtII and did not use sphingomyelin as membrane 
target (Glasser et al. 2014). These findings may not be surprising, since HALT-1 and EqtII share 
only 30% similarity in protein sequence and several amino acid residues known to be involved in 
sphingomyelin binding in equinatoxin and sticholysin are not conserved in HALT-1 (Liew et al 
2015).  
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Although numerous experiments support a critical role for sphingomyelin as the 
membrane attachment site for sea anemone antinoporins (Bakrač and Anderluh 2010), some 
reports suggested otherwise. For example, De los Ríos et al. (1998) and Caaveiro et al. (2001) 
tested the lytic action of StnII and EqtII with model membranes having different lipid 
compositions.  Their results showed that these toxins appeared to have the ability to bind to and 
permeabilize membranes in the absence of sphingomyelin. In fact, EqtII was able to 
permeabilize large unilamellar vesicles (LUV) containing 30% cholesterol in egg 
phosphatidylcholine (Caaveiro et al. 2001) as well as LUVs composed of 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC), 1,2-dipalmitoyl-sn-glyerol-3-phosphocholine (DPPC) and 
cholesterol (1:1:1) (Schön et al. 2008). A similar result was obtained with another actinoporin, 
sticholysin of Stichodactyla helianthus.  This actinoporin was able to permeabilize LUVs 
composed only of cholesterol and phosphatidylcholine (De los Ríos et al. 1998; Anderluh and 
Maček 2003; Kristan et al. 2009). Thus, at least in some in vitro experiments, sphingomyelin is 
not required for membrane permeabilization by actinoporins.  
In the present study, we have searched for alternative membrane receptors, in 
particular membrane proteins, which could play a role in HALT-1 permeabilization of 
membranes. The cell membrane is a complex mixture of lipids and proteins and both are 
functionally important in many cellular processes including as a barrier to separate the interior of 
the cell from its environment, to selectively transport substances across the membrane and to act 
as membrane-bound receptors or mediators of signal transduction (Fernandis and Wenk 2007). A 
few bacterial pore-forming toxins have been proven to bind proteinaceous receptors in addition 
of their affinity to membrane lipids (Dal Peraro and van der Goot 2016; DuMont and Torres 
2014). These pore-forming toxins include the intermedilysin (ILY) of Streptococcus intermedius 
which recognises CD59, an GPI-anchored protein, as the membrane receptor although it has 
been classified as a cholesterol-dependent cytolysin (Giddings et al. 2004). Hence, membrane 
proteins can be potential candidates as receptors for HALT-1.  
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Since the attempt to show sphingomyelin as an important membrane target site for 
HALT-1 was not successful (Glasser et al 2014) and there has been no information on membrane 
protein binding, we used a combination of GST affinity purification and SILAC based 
quantitative mass spectrometry to identify potential membrane proteins that bind to HALT-1. 
This combination offered a powerful approach to identify complexes associated with signalling 
mechanisms (Ong and Mann 2006), including those involving low abundant proteins and weak 
protein interactions (Bauer and Kuster 2003). Using this approach we have identified a 
membrane protein, which appears to have a role in the binding of HALT-1 to membranes.  
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2. Materials and Methods 
 
2.1. Plasmid construction  
 For the construction of glutathione-S-transferase-tagged (GST-tagged) at N-terminus 
of HALT-1 fusion protein, the Gateway cloning system (Invitrogen-Life Technologies, USA) 
was performed according to the manufacturer’s instruction. Prior to the gene cloning, HALT-1 
was amplified from HALT-1-pCR4-TOPO using Phusion® High Fidelity DNA Polymerase 
(New England BioLabs, USA) and a pair of primers (forward primer 5’-
CACCGCCAGTGGAGCAGCTTTAG-3’ and reverse primer 5’- 
TTATCCAGAAAAAATAACTTTGAACTCAGCATGG-3’). The amplicon was then cloned 
into pENTR™/D-TOPO® Entry Vector using Directional TOPO cloning system to generate the 
Entry clone, and followed by the transformation into One Shot® TOP10 competent cells. To 
produce the expression vector containing GST-tagged at the N-terminus of HALT-1, the HALT-
1 Entry clone was sub-cloned into pDEST™15 Destination vector using LR recombination 
reaction system and then transformed into Library Efficiency® DH5α cells. The construct of 
recombinant GST-tagged HALT-1 was finally verified by sequencing.  
 
2.2. Protein expression and purification 
 The recombinant GST-tagged HALT-1 was expressed in BL21-AI™ One Shot® E. 
coli with L-(+)-arabinose induction (0.2%) for 4 hours at 30°C. After the expression, the cells 
were harvested by centrifugation at 10,000 xg for 5 min. Subsequently, the arabinose-induced 
culture was re-suspended in equilibration buffer (50 mM Tris.HCl, 150 mM NaCl, pH 8.0) with 
additional protease inhibitor PMSF (0.1 mM), and the cells were lysed by sonication at 500 watts 
and 20 kHz. The lysate was centrifuged 2,200 xg for 15 min. For protein purification, a total of 
50-200 mg soluble fraction of cell lysate were subjected to affinity chromatography of 
glutathione agarose (Thermo Fisher Scientific, USA). Purified GST-tagged HALT-1 fusion 
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protein was concentrated and exchanged buffer with BupH Tris buffer using Amicon® Ultra-2 
(Merck Millipore, USA). As based on the manufacturer’s protocol of Quick Start Bradford 
Assay (Bio-Rad, USA), the final concentration of purified GST-tagged HALT-1 protein was 
measured as 10.8 µg/µL. 
 
2.3. Cell culture and SILAC labelling  
HeLa cells (ATCC® CCL-2™) were routinely maintained in Dulbecco’s modified 
Eagle’s medium (Gibco/Invitrogen-Life Technologies, USA) supplemented with 10% dialyzed 
fetal bovine serum (FBS) and 1% penicillin-streptomycin at 37°C in 5% CO2 atmosphere. For 
SILAC labelling, the incorporation of “light” and “heavy” amino acids into cells was carried out 
using SILAC Protein Identification (ID) and Quantitation Kits (Gibco/Invitrogen-Life 
Technologies, USA) according to the manufacturer’s instruction. Two sets of HeLa cells were 
grown separately in two different custom-made SILAC media, in which one group of cells was 
grown in normal or “light” medium containing 100 mg/mL of L-lysine HCl and 100 mg/mL of 
L-Arginine and the other group of cells was grown in labelling or “heavy” medium containing 
100 mg/ mL of [U-13C6]-L-Lysine HCl (*Lys) and 100 mg/mL of L-Arginine. Both “light” and 
“heavy” media were supplemented with 4,500 mg/L of glucose, 292 mg/L of L-glutamine, 110 
mg/L of sodium pyruvate, 15 mg/mL of phenol red, 1% of penicillin-streptomycin and 10% 
dialyzed FBS. “Light” and “heavy” labelled cell populations were passaged for at least 9 
doubling times to achieve complete incorporation of [U-13C6]-L-Lysine HCl (*Lys) (Ong et al. 
2002, 2003; Ong and Mann 2006). Both cell cultures were grown at 37°C in a humidified 
incubator of 5% CO2 atmosphere. After cell adaptation, the efficiency of SILAC incorporation 
into the culture was determined to be >95% by mass spectrometry analysis. The percentage of 
SILAC incorporation was calculated manually using the following equation: Incorporation (%) = 
[Ratio (H/L) / (Ratio (H/L) + 1)] x 100 (Oeljeklaus et al. 2014). 
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2.4. Preparation of cell lysates 
For sample preparation, both “light” and “heavy” labelled HeLa cell populations were 
separately grown to approximately 90% confluence in their respective SILAC media as 
described above. After that, the medium was removed and cells were washed with 0.9% sterile 
NaCl, scrapped in 0.9% sterile NaCl and centrifuged at 200 xg for 5 min at 4°C. Whole cell 
extracts were prepared by dissolving cells in Pierce IP lysis buffer (Thermo Fisher Scientific, 
USA) (25 mM Tris.HCl pH 7.4, 150 mM NaCl, 1% NP-40, 1 mM EDTA and 5% glycerol) with 
addition Halt™ Protease Inhibitor Single-Use Cocktail (Thermo Fisher Scientific, USA). Two 
cell suspensions were incubated for 7 min on ice with maximum agitation and subsequently 
pelleted with centrifugation at 13,000 xg for 10 min at 4°C. Supernatants of “light” and “heavy” 
labelled cell suspensions were ready for the GST affinity purification.  
 
2.5. Affinity purification of GST-tagged HALT-1 binding proteins 
To identify HALT-1 binding proteins in cell lysates we used a recombinant GST- 
HALT-1 fusion protein bound to glutathione agarose beads. Briefly, a total of 12 mg HeLa lysate 
from SILAC “heavy” medium was incubated with the GST-tagged HALT-1 protein (300 µg) 
immobilized on agarose beads for 30 min at 4°C. After washing nonspecific proteins from the 
column, the SILAC-labelled HeLa proteins that bound to HALT-1 were eluted with 2 mL of 
elution buffer (50 mM Tris.HCl, 150 mM NaCl, 10 mM reduced glutathione, pH 3.0). As a 
control for non-specific binding, an equal protein amount (12 mg) of HeLa lysate from the 
SILAC “light” medium was incubated with glutathione agarose beads only, followed by washing 
and elution. To replicate the experiment, the entire procedure was repeated with the “heavy” and 
“light” SILAC labels reversed. The HeLa cell lysate from “light” medium was incubated with 
the GST-HALT-1 fusion protein immobilized on glutathione agarose beads, whereas the HeLa 
cell lysate from “heavy” medium was incubated with glutathione agarose beads alone.  
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Equal amount of eluted proteins from “heavy” and “light” cell lysates were analysed in 
12% sodium dodedyl suphate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by zinc 
staining and mass spectrometry analyses.  
 
2.6. Liquid chromatography-tandem mass spectrometry and data analysis  
Pooled proteins obtained from the affinity purification were incorporated into a 
polyacrylamide gel matrix to form a tube-gel (Lu and Zhu 2005) and sent to the Protein and 
Proteomic Centre, National University of Singapore for the liquid chromatography–tandem mass 
spectrometry (LC-MS/MS). In brief, the polyacrylamide gel was excised and further processed 
to in-gel reduction, alkylation, trypsin in-gel digestion and sample desalting/clean up according 
to the standard in-gel digestion protocol as described previously with minor modifications 
(Fukada et al. 2004; Lu and Zhu 2005). The finely cut gels were washed with 25 mM ammonium 
bicarbonate (AMBIC) and dehydrated with 100% acetonitrile (ACN). Subsequently, the samples 
were reduced with 10 mM dithiothreitol (DTT) for 30 min at 60°C, followed by alkylation with 
55 mM iodoacetamide (IAA) for 30 min at room temperature in the dark. The gel pieces were 
then washed with 25 mM AMBIC, dehydrated with ACN and dried using vacuum centrifuge. 
After that, the samples were incubated overnight at 37°C with 10 ng/µL trypsin in 25 mM 
AMBIC for proteolytic digestion of proteins. On the following day, the peptides were extracted 
from the gel using 50 µL of 25 mM AMBIC, 100 µL of 0.02% heptafluorobutyric acid (HFBA) 
in deionised water, 150 µL of 0.02% HFBA in 50% ACN and 50 µL of 100% ACN. Hence, four 
different supernatant fractions from the peptides extraction steps were subsequently pooled 
together, lyophilized using vacuum centrifuge and desalted prior subjected to LC-MS/MS. 
Separation of peptides from tryptic peptide mixture was carried out using Eksigent Nano-liquid 
chromatography (AB SCIEX, USA) for 100 minutes, followed by the MS analysis using Triple 
TOF 5600 system (AB SCIEX, USA). To identify the proteins, the mass spectra acquired from 
the mass spectrometry were searched against the human and decoy (reversed) databases using a 
Paragon™ Algorithm (Shilov et al. 2007), ProteinPilot software package version 4.5 (AB 
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SCIEX, USA). The target-decoy approach was set at 5% of false discovery rate (FDR) (Choi and 
Nesvizhskii 2008; Elias and Gygi 2010).  
 
2.7. Statistical data analysis  
The data files acquired from LC-MS/MS were viewed and further processed with 
ProteinPilot version 4.5 software. Here, the data were normalized using global median 
normalization that shifted the centre of the distribution to zero without affecting the spread. For 
protein identification and quantitation, only proteins with minimum of 2 unique peptides and 
proteins that were identified in the experimental replicates with 95% confidence were considered 
as the candidate protein interactors. In addition, the fold-change approach (SILAC (H/L) ≥ 2.0 
fold) was applied to identify protein interaction partners and hence, identified proteins with low 
fold-change value from the threshold were discarded. The protein SILAC ratio and its intensity 
values were inverted for the “reversed” experiment mentioned in 2.5 of this section.  
For statistical analysis, Student’s t-test (paired sample) followed by the multiple testing 
Benjamini-Hochberg correction was used to obtain the statistical significance value (p-value < 
0.05) (Benjamini and Hochberg 1995), using the Statistical Package for the Social Sciences 
(SPSS) software, version 23.  
 
2.8. Bioinformatics analysis 
The information of subcellular localization, molecular function and biological process 
of the identified proteins were obtained from Gene Ontology (GO) (http://geneontology.org) 
(Ashburner et al. 2000; The Gene Ontology Consortium 2015) and UniProt 
(http://www.uniprot.org) (The UniProt Consortium 2017).  
 
2.9. Enzyme linked immunosorbent assay (ELISA) 
19.69 nM of human recombinant folate receptor alpha (FOLR-1, Sigma-Aldrich, USA) 
was immobilized on the immunoplate (SPL 96-well immunoplate, SPL Sciences Co., Ltd., 
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Korea) overnight at 4°C. On the next day, the wells were emptied and washed 3 times with 150 
µL of PBST buffer (PBS with 0.2% of Tween-20) for 5 min each. The unoccupied protein-
binding sites in wells were blocked by adding 200 µL of 1% BSA in PBS buffer (pH 7.4) and 
further incubation at room temperature for 2 hours. After a routine washing process, 100 µL of 
HALT-1 (20, 40, 80, 160, 320 and 400 nM) were added to the wells and incubated for 2 hours at 
room temperature. The wells were rinsed three times with PBST buffer before incubating with 
100 µL of rabbit a-HALT-1 antibody (1:2000). Then, 100 µL of goat a-rabbit IgG-AP (1:8000) 
(Santa Cruz Biotechnology, USA) were added and incubated at room temperature for 2 hours. 
After three rinses, 50 µL of substrate 4-MUP (4-methylumbelliferyl-phosphate, Sigma-Aldrich, 
USA) was added to each well to develop the fluorescent signal. Measurement of the fluorescent 
signal (excitation/emission at 355/460 nm) was performed by a multi-mode microplate reader 
(BMG Labtech, Germany). The intra-assay variability was calculated from the average of 
triplicate wells in one microplate.  
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3. Results and Discussion 
 
3.1 Identification of potential HALT-1 interaction partners 
To identify HALT-1-interacting proteins that could mediate HALT-1 membrane binding, 
we performed a comprehensive proteomic analysis using SILAC-based quantitative affinity 
purification and mass spectrometry (SILAC-based q-AP-MS).  The schematic workflow of this 
experiment is presented in Fig.1 including SILAC labelling, affinity purification (by GST pull-
down) and LC-MS/MS. The SILAC procedure was used to distinguish protein(s) binding to 
HALT-1 from nonspecific proteins binding to the glutathione matrix. We first tested the 
efficiency of SILAC incorporation in HeLa cells after 9 doubling times in SILAC media and its 
influence on the accuracy and reliability of quantitative mass spectrometry. For this experiment, 
only heavy labelled HeLa cells were prepared and subsequently processed for protein 
quantification by LC-MS/MS. The result showed a SILAC-labelling efficiency of 97.33% in 
HeLa cells, indicating that nearly all peptides or proteins were labelled with SILAC lysine 
residue (Supplementary Fig. S1). This level of SILAC labelling in HeLa cells was considered 
satisfactory, since it fell within the range (95-97%) reported in other SILAC labelling 
experiments (Zhu et al. 2002; Waanders et al. 2007).  
To identify potential HALT-1 interacting proteins a “heavy” cell lysate was added to a 
column containing GST-tagged HALT-1 immobilized on glutathione agarose beads while a 
“light” cell lysate was added to a column containing only glutathione agarose beads. In a second 
experiment, the labels were reversed: the “light” cell lysate was added to GST-tagged HALT-1 
immobilized on glutathione agarose beads and the “heavy” cell lysate was added to the column 
containing glutathione agarose alone. Two pools of proteins collected separately from the eluate 
fractions of two individual experiments described above were examined by 12% SDS-PAGE gel 
electrophoresis under reducing condition and then visualized by zinc stain (Supplementary Fig. 
S2) before they were combined for LC-MS/MS analysis. Data of LC-MS/MS were analysed 
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against the human and decoy (reversed sequences) database using Paragom™ Algorithm, 
ProteinPilot software package (version 4.5, AB SCIEX, USA). In brief, a total of 2,458 and 
1,752 tandem mass spectra were generated from the two experimental replicates, respectively. 
Subsequently these two numbers resulted in 105 and 117 unique proteins. By using ProteinPilot, 
we normalized the mass spectrometry data result with global median normalization with aims to 
minimize the variation between the two data sets. Subsequently, we carried out the quantitation 
analysis for each peptide and removed proteins which did not have at least 2 unique peptide hits 
at 5% FDR (False Discovery Rate). As a result, lists comprising of 41 and 32 protein hits were 
generated and compiled in tables 1 and 2, respectively. Instead of a direct calculation of “heavy” 
(H) over “light” (L) ratio, ProteinPilot used correction algorithm to measure the percentage error 
due to various experimental bias. These proteins varied in their SILAC (H/L) ratios and were 
localized in various subcellular compartments as determined by the Gene Ontology.  
To further strengthen the selection of interaction partners for HALT-1, only proteins with 
SILAC (H/L) ratios ≥2.0 with significant confidence level at 95% (p-value < 0.05) were 
considered as possible interaction partners for HALT-1. These putative interaction partners of 
HALT-1 have to be present in both tables 1 and 2, and they include 60S ribosomal protein L12, 
60S acidic ribosomal protein P2, folate receptor alpha and nucleolin (Table 3). Figure 2 
demonstrated that the intensities of “light” and “heavy” labelled peptides differ by at least 2.0 
fold in the MS/MS spectra for each putative HALT-1 interactor (Fig. 2). Of the four putative 
HALT-1 interactors, we eliminated nucleolin, 60S ribosomal protein L12, and 60S acidic 
ribosomal protein P2 as nonspecific binding partners, since they are abundant intracellular 
proteins and are known to interact with affinity matrices such as sepharose (Gingras et al. 2007; 
Trinkle-Mulcahy et al. 2008). Furthermore, they are commonly detected protein contaminants in 
q-AP-MS experiments (Oeljeklaus et al. 2009). Therefore, we focused our attention on one 
candidate, folate receptor alpha, which gave a strong H/L signal in both experiments and is 
located on the cell membrane and thus a potential target for HALT-1.  
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3.2 Verification of folate receptor alpha binding to HALT-1 
To verify the interaction between HALT-1 and folate receptor alpha, we performed an 
ELISA binding assay with various HALT-1 concentrations to folate receptor alpha that was 
coated on the well surface of immunoplate. Figure 3 shows that HALT-1 bound to folate 
receptor alpha in a dose-dependent manner ranging from 0 to 400 nM (or 0 to 10 µg/mL). The 
intensity of signal has not reached a plateau because the amount of HALT-1 has yet to saturate 
the coated FOLR1 but the antibodies used was enough to give a discernible detection signal at 
the highest concentration of HALT-1. Controls lacking either folate receptor alpha, HALT-1, 
anti-HALT-1 antibody or secondary antibody resulted in very low or insignificant signals. 
Therefore, there was a direct, in vitro binding of HALT-1 to folate receptor alpha suggesting a 
possible involvement of folate receptor alpha in the mechanism of HALT-1 induced cell lysis. 
 
3.3 Concluding remarks 
The folate receptor alpha is a GPI-anchored (glycosylphosphatidylinositol-anchored) 
membrane protein of 38-40 kDa that plays a major role in the uptake of folate/folic acid into 
cells via endocytosis (Luhrs and Slomiany 1989; Basal et al. 2009). Folate receptor alpha is 
attached to the GPI anchor via its C-terminal end (Paulick and Bertozzi 2008; Maeda and 
Kinoshita 2011). Therefore, the folate receptor alpha is localized on the outer surface of the cell 
membrane and could serve as the membrane attachment site for extracellular proteins, possibly 
including HALT-1. This hypothesis is supported by the fact that the alpha-toxin of Clostridium 
septicum binds to the GPI-anchored form of folate receptor alpha (Gordon et al. 1999) before it 
is cleaved approximately 4 kDa from the C-terminus to become an active cytolysin (Melton-Witt 
et al. 2006). Similarly, we suggest that folate receptor alpha could serve as a membrane receptor 
for HALT-1 instead of the lipid sphingomyelin, which has been previously thought to be the 
solely attachment site for HALT-1 on the cell membrane (Liew et al. 2015). This idea is 
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supported by the results of Glasser et al. (2014) who pointed out the likelihood of an alternative 
binding site for HALT-1. In brief, these authors compared the binding affinity of sphingomyelin 
to HALT-1 and EqtII in a haemolysis assay. Their results clearly showed that the concentration 
of sphingomyelin that fully inhibited the haemolytic activity of EqtII failed to block the 
haemolytic activity of HALT-1. Thus, the binding affinity of HALT-1 to sphingomyelin is at 
least 100-fold weaker than that of EqtII. HALT-1 also lacks conserved amino acids in the 
sphingomyelin binding site.      
We cannot totally rule out the possibility that HALT-1 binds to more than one attachment 
sites on cell membrane since some bacterial pore-forming toxins are able to bind more than one 
membrane receptors. A good example is the intermedilysin (ILY) of Streptococcus intermedius 
which recognises CD59, an GPI-anchored protein, as the membrane receptor although it has 
been classified as a cholesterol-dependent cytolysin (Giddings et al. 2004). a-hemolysin of 
Staphylococcus aureus is another example of PFTs binding to multiple membrane target sites. a-
hemolysin has been known to have a low affinity to phosphocholine head groups but it was later 
proven to interact with ADAM10 (a disintegrin and metalloprotease 10) which is a 
transmembrane protease present in wide variety of cells (Valeva et al. 2006; Wilke and 
Wardenburg 2010).  
In summary, by a combination of affinity purification and SILAC-based quantitative 
mass spectrometry we have identified the folate receptor alpha as an interaction partner of 
HALT-1. This result provides an alternative to the previously established binding of HALT-1 to 
the lipid sphingomyelin. By identifying the potential membrane receptors for HALT-1, we have 
unravelled the essential step in the lytic mechanism by Hydra’s toxin. The next step is to gain a 
deeper understanding of the possible role of folate receptor alpha in pore formation. This is 
particularly crucial to understand how the initial toxin-membrane receptor interaction leads to 
the subsequent adverse effects or illness in host body. The findings of this study also provided a 
broad implication for making anti-PFTs therapies that aims to disrupt the toxin-membrane 
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receptor interactions. For most toxins, their interactions with membrane receptors are highly 
specific and hence the therapies can target these specific interactions and leave other receptor 
sites unharmed.  
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TABLE 1 List of “heavy” labelled proteins interacting to HALT-1 in GST affinity purification 
  
Accession 
numbera 
Protein name Subcellular location Molecular weight 
(kDa) 
Intensity 
L 
Intensity 
H 
Ratio 
H/Lb 
Number 
of unique 
peptidesc 
P30050 60S ribosomal protein L12 Cytoplasm, cytosol, 
nucleus, nucleolus 
17.819 0 428.29 100 5 
Q9HAV7 GrpE protein homolog 1, 
mitochondrial 
Mitochondrion matrix, 
nucleus 
24.279 2.74 154.31 24.75 2 
P04899 Guanine nucleotide-binding 
protein G(i) subunit alpha-2 
Cytoplasm, cell 
membrane 
40.451 11.27 107.29 6.93 2 
P05387 60S acidic ribosomal protein P2 Cytosol, cell membrane 11.665 116.93 1690.2 6.35 11 
Q12905 Interleukin enhancer-binding 
factor 2 
Nucleus, cytoplasm 43.062 21.04 252.25 5.27 2 
P19338 Nucleolin Nucleus, cytoplasm, cell 
membrane 
76.614 49.86 646.02 5.20 17 
P15328 Folate receptor alpha Cell membrane 29.819 81.51 895.81 4.83 4 
P05386 60S acidic ribosomal protein P1 Cytoplasm, cytosol 11.514 43.43 473.75 4.79 2 
P25398 40S ribosomal protein S12 Cytoplasm, cytosol 14.515 35 299.37 3.78 6 
P08174 Complement decay-accelerating 
factor 
Cell membrane 41.400 39.07 202.53 3.68 5 
P53999 Activated RNA polymerase II 
transcriptional coactivator p15 
Nucleus 14.395 21.88 120.46 2.42 2 
P05186 Alkaline phosphatase, tissue-
nonspecific isozyme 
Cell membrane 57.305 23.74 123.86 2.29 2 
P05388 60S acidic ribosomal protein 
P0-like; 60S acidic ribosomal 
protein P0 
Cytosolic large ribosomal 
subunit, preribosome, 
large subunit precursor; 
Nucleus, cytoplasm 
34.274 41.4 195.91 2.01 5 
P60660 Myosin light polypeptide 6 Cytosol, membrane 16.930 109.17 458.44 1.81 11 
Q9NYL9 Tropomodulin-3 Cytoplasm, cytoskeleton 39.595 29.26 110.525 1.72 2 
P11021 78 kDa glucose-regulated 
protein 
Endoplasmic reticulum 
lumen, melanosome, 
cytoplasm 
72.333 41.985 158.80 1.72 4 
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TABLE 1 List of “heavy” labelled proteins interacting to HALT-1 in GST affinity purification (continue) 
 
Accession 
numbera 
Protein name Subcellular location Molecular weight 
(kDa) 
Intensity 
L 
Intensity 
H 
Ratio 
H/Lb 
Number 
of unique 
peptidesc 
P61604 10 kDa heat shock protein, 
mitochondrial 
Mitochondrion matrix 10.932 53.54 185.32 1.52 2 
P62158 Calmodulin Cytoplasm, cytoskeleton 16.838 434.43 1380.96 1.40 7 
P07355 Annexin A2 Basement membrane, 
extracellular matrix 
38.604 89.47 250.96 1.23 6 
P23528 Cofilin-1 Cell membrane, cell 
projection, cytoplasm, 
cytoskeleton, nucleus 
18.502 88.9 236.91 1.17 3 
P07737 Profilin-1 Cytoplasm, cytoskeleton 15.054 80.84 210.89 1.14 3 
P10809 60 kDa heat shock protein, 
mitochondrial 
Mitochondrion matrix 61.055 152.41 365.8 1.12 11 
P14618 Pyruvate kinase PKM Cytoplasm, nucleus 57.937 64.2 145.95 1.10 5 
P21796 Voltage-dependent anion-
selective channel protein 1 
Mitochondrion outer 
membrane, cell membrane, 
membrane raft 
30.773 47.39 117.57 1.09 2 
P47756 F-actin-capping protein subunit 
beta 
Cytoplasm, cytoskeleton 31.350 50.8 124.31 1.08 3 
P04406 Glyceraldehyde-3-phosphate 
dehydrogenase 
Cytoplasm, cytosol, 
cytoskeleton, nucleus, 
membrane 
36.053 102.65 248.98 1.07 2 
P06733 Alpha-enolase Cytoplasm, membrane, 
nucleus 
47.169 106.52 247.3 0.94 11 
P08238 Heat shock protein HSP 90-beta Cytoplasm 83.264 80.33 154.37 0.89 4 
P63104 14-3-3 protein zeta/delta Cytoplasm, melanosome 27.745 102.82 192.28 0.82 3 
P61978 Heterogeneous nuclear 
ribonucleoprotein K 
Cytoplasm, nucleus, cell 
projection 
50.976 84.81 158.17 0.82 2 
Q06830 Peroxiredoxin-1 Cytoplasm, melanosome 22.110 73.07 129.72 0.78 3 
P68104 Elongation factor 1-alpha 1 Cytoplasm, nucleus 50.141 849.55 1293.57 0.65 23 
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TABLE 1 List of “heavy” labelled proteins interacting to HALT-1 in GST affinity purification (continue) 
a Accession number is the unique identifier assigned to the entire sequence record when the record is submitted to GenBank. 
b Ratio of signal intensities of “heavy” and “light” sample pair are calculated by ProteinPilot with default setting to determine the relative level of 
protein in the two samples. It is calculated with the weighted average of log ratio of individual peptides belonging to the same protein after 
background subtraction.  
c The number of distinct peptides that match to a single protein when MS/MS spectra is searched against a sequence database. 
 
  
Accession 
numbera 
Protein name Subcellular location Molecular weight 
(kDa) 
Intensity 
L 
Intensity 
H 
Ratio 
H/Lb 
Number 
of unique 
peptidesc 
P24534 Elongation factor 1-beta Cytoplasm, cytosol 24.764 1460.27 1909.27 0.57 15 
O43813 LanC-like protein 1 Cytoplasm,membrane 45.283 1420.34 1866.21 0.56 14 
P26641 Elongation factor 1-gamma Cytoplasm, cytosol, 
membrane, nucleus, 
extracellular exosome 
50.119 1232.23 1538.48 0.55 19 
Q9NS18 Glutaredoxin-2, mitochondrial Mitochondrion, nucleus 18.052 254.9 196.13 0.34 2 
Q03013 Glutathione S-transferase Mu 4 Cytoplasm, cytosol 25.561 150.83 108.36 0.32 2 
P16152 Carbonyl reductase [NADPH] 1 Cytoplasm 30.375 3779.61 2653.005 0.29 79 
P21266 Glutathione S-transferase Mu 3 Cytoplasm 26.560 5079.25 3246.36 0.27 51 
P09488 Glutathione S-transferase Mu 1 Cytoplasm, cytosol 25.712 2459.63 1424.43 0.25 17 
P09211 Glutathione S-transferase P Cytoplasm, nucleus 
mitochondrion,  
23.356 1888.39 672.05 0.17 31 
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TABLE 2  List of “light” labelled proteins interacting to HALT-1 in GST affinity purification 
Accession 
numbera 
Protein name Subcellular localization Molecular weight 
(kDa) 
Intensity 
L 
Intensity 
H 
Ratio 
H/Lb 
Number 
of unique 
peptidesc 
P30050 60S ribosomal protein L12 Cytoplasm, cytosol, 
nucleus, nucleolus 
17.819 1179.355 41.075 8.43 6 
P15328 Folate receptor alpha  Cell membrane 29.819 1951.14 78.44 7.10 5 
P05387 60S acidic ribosomal protein P2  Cytoplasm, cytosol,  cell 
membrane 
11.665 1108.02 50.19 6.30 5 
P14923 Junction plakoglobin  Cell junction, cytoplasm, 
cell membrane 
81.745 105.345 51.955 5.16 2 
P60660 Myosin light polypeptide 6  Cytosol, cell membrane 16.930 19267.6 1136.03 4.84 12 
P19338 Nucleolin Nucleus, cytoplasm, cell 
membrane 
76.614 743.97 59.785 3.54 6 
Q96C19 EF-hand domain-containing 
protein D2  
Membrane raft 26.697 423.78 82.84 1.46 4 
P60709 Actin, cytoplasmic 1  Cytoplasm, cytoskeleton 41.737 3327.33 818.91 1.35 22 
P52907 F-actin-capping protein subunit 
alpha-1  
Cytoplasm, cytoskeleton 32.923 224.855 47.815 1.34 4 
P38646 Stress-70 protein, mitochondrial Mitochondrion, nucleus 73.680 260.65 56.87 1.31 2 
P80723 Brain acid soluble protein 1  Cell membrane, cell 
projection 
22.693 378.81 100.21 1.08 3 
P07355 Annexin A2  Basement membrane, 
extracellular matrix 
38.604 604.02 167.47 1.03 7 
Q13813 Spectrin alpha chain, non-
erythrocytic 1  
Cytoplasm, cell cortex, 
cytoskeleton 
284.539 287.7 83.165 0.94 2 
Q09666 Neuroblast differentiation-
associated protein AHNAK  
Nucleus, cytoplasm, Cell 
membrane 
629.101 393.555 40.63 0.86 3 
P62258 14-3-3 protein epsilon  Cytoplasm, melanosome 29.174 264.94 119.03 0.64 2 
P08238 Heat shock protein HSP 90-beta Cytoplasm, melanosome 83.264 280.39 133.94 0.60 2 
Q9BQE3 Tubulin alpha-1C chain  Cytoplasm, cytoskeleton, 
microtubule, nucleus 
49.895 284.075 154.635 0.52 4 
P10809 60 kDa heat shock protein, 
mitochondrial 
Mitochondrion matrix 61.055 376.11 209.57 0.51 2 
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TABLE 2 List of “light” labelled proteins interacting to HALT-1 in GST affinity purification (continue) 
a Accession number is the unique identifier assigned to the entire sequence record when the record is submitted to GenBank. 
b Ratio of signal intensities of “heavy” and “light” sample pair are calculated by ProteinPilot with default setting to determine the relative level of 
protein in the two samples. It is calculated with the weighted average of log ratio of individual peptides belonging to the same protein after 
background subtraction. The values of ratio H/L are inverted to keep consistency with the values presented in table 1. 
c The number of distinct peptides that match to a single protein when MS/MS spectra is searched against a sequence database. 
Accession 
numbera 
Protein name Subcellular localization Molecular weight 
(kDa) 
Intensity 
L 
Intensity 
H 
Ratio 
H/Lb 
Number of 
unique 
peptidesc 
Q06830 Peroxiredoxin-1  Cytoplasm, melanosome, 
nucleus, mitochondrion 
22.110 136.1 76.53 0.51 2 
P07737 Profilin-1 Cytoplasm, cytoskeleton 15.054 181.58 104.73 0.49 3 
P21333 Filamin-A  Cytoplasm, cytoskeleton, 
cell cortex, cell 
membrane, nucleus 
280.739 130.06 75.28 0.49 2 
P07900 
 
Heat shock protein HSP 90-
alpha 
Cytoplasm, melanosome, 
cell membrane, nucleus 
84.660 190.47 
 
110.995 
 
0.492 
 
2 
 
P04075 Fructose-bisphosphate aldolase 
A  
Cytoplasm, nucleus 39.420 228.03 138.29 0.47 3 
P29401 Transketolase Cytosol, nucleus 67.878 240.97 156.35 0.44 2 
P68104 Elongation factor 1-alpha 1  Cytoplasm, nucleus;  50.185 1980.16 1423.34 0.40 19 
P26641 Elongation factor 1-gamma  Nucleus, nucleolus, 
cytoplasm, cytosol, cell 
membrane 
50.141 9287.73 7228.4 0.37 16 
P24534 Elongation factor 1-beta  Cytoplasm, cytosol 24.764 1415.67 1199.09 0.34 9 
O43813 LanC-like protein 1  Cytoplasm, cell 
membrane 
45.283 3572.97 3836.755 0.27 10 
P21266 Glutathione S-transferase Mu 3  Cytoplasm, nucleus 26.560 1546.04 1623.75 0.26 30 
P16152 Carbonyl reductase [NADPH] 1  Cytoplasm 30.375 1221.59 1564.41 0.22 14 
P09488 Glutathione S-transferase Mu 1 Cytoplasm 25.712 572.76 766.11 0.21 12 
P09211 Glutathione S-transferase P  Cytoplasm, 
mitochondrion, nucleus, 
cell membrane 
23.356 2163.21 4528.79 0.14 2 
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TABLE 3  Summary of putative HALT-1 interaction proteins after normalization 
Accession 
numbera 
Gene 
name 
Protein name Normalized 
“heavy” 
SILAC ratio 
Normalized 
“light” 
SILAC ratio 
Significance 
levelb 
P30050 RPL12 60S ribosomal protein 
L12 
100.00 8.42 3.22746E-04 
P05387 RPLP2 60S acidic ribosomal 
protein P2 
6.35 6.30 3.97908E-05 
P15328 FOLR1 Folate receptor alpha 4.83 7.10 2.03048E-04 
P19338 NCL Nucleolin 5.20 3.54 8.075E-09 
a Accession number is the unique identifier assigned to the entire sequence record when the 
record is submitted to GenBank. 
b The statistical significant value shall be p-value < 0.05.  
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Figure Legend 
 
Fig. 1. Schematic workflow of GST affinity purification and SILAC-based quantitative 
mass spectrometry for identification of HALT-1 interacting partners. HeLa cells were 
grown in either “light” (L-Lysine HCl) or “heavy” ([U-13C6]-L-Lysine HCl) SILAC medium 
for 9 cell-doubling times. Whole cell lysate was subjected to GST affinity purification of which 
one column containing “light” labelled cell lysate with GST resin alone and the other column 
containing “heavy” labelled cell lysate with GST resin conjugated to GST-tagged (N-terminus) 
HALT-1. After washing, the bound proteins were independently eluted from both columns and 
then mixed equally before subjected to tube-gel digestion and LC-MS/MS based analysis. A 
low “light” MS ion peak together with an at least 2.0-fold higher “heavy” MS ion peak 
indicates as the putative protein interactor for HALT-1. For the second experiment, the 
procedure was performed in the same manner as described above except that the “light” 
labelled cell lysate and the “heavy” labelled cell lysate were reversed in the GST affinity 
purification. 
 
Fig. 2. MS/MS spectra representing a SILAC unique peptide pair of RPL12, RPLP2, 
FOLR1 and NCL. Four HALT-1 interaction partners are unambiguously detected by LC-
MS/MS and each putative protein has its “heavy” and “light” peptides appear on the same 
MS/MS spectrum. A and B, 60S ribosomal protein L12 (RPL12); C and D, 60S acidic 
ribosomal protein P2 (RPLP2); E and F, folate receptor alpha (FOLR1); G and H, nucleolin 
(NCL). A, C, E and G show the “heavy” peptides that are derived from the incubation with 
GST-tagged (N-terminus) HALT-1. Whereas, B, D, F and H show the “light” peptides that are 
derived from the incubation with GST-tagged (N-terminus) HALT-1. The ordinate indicates 
the relative intensity or abundance of peptides while the abscissa indicates the mass-to-charge 
ratio (m/z). Red vertical line indicates the position of “light” or “heavy” labelled pair of 
peptides in the spectrum. The sequence of SILAC peptide is shown on the right hand corner 
above the spectrum. 
 
Fig. 3. Immobilized FOLR-1 ELISA. Data demonstrated the specific binding of FOLR-1 by 
Hydra HALT-1. The mean of fluorescent signal for triplicate experiments was measured with 
various concentrations of HALT-1. Standard deviation was calculated from the triplicate 
results and indicated by the upper and lower error bars at each data point. Control without 
either FOLR-1  ( ), anti-HALT-1 antibody ( ) or goat anti-rabbit IgG (X) was carried out at 
the highest concentration of HALT-1 (400 nM or 10 µg/mL). 
	 31 
Supplementary Figure Legend 
 
Supplementary Fig. S1. SILAC incorporation in HeLa cells after 9 doubling times. 
Vertical dashed line indicates the percentage of SILAC labelling efficiency (97.33%). X-axis 
represents the incorporation levels of SILAC amino acid, “heavy” ([U-13C6]-L-Lysine HCl); 
and y-axis represents the probability of peptides that were coupled with SILAC amino acid. 
 
Supplementary Fig. S2. Electrophoretic analysis of the pool of eluate fractions after GST 
affinity purification. Lane 1, unstained protein ladder with broad range 10-250 kDa; lane 2, 
purified recombinant GST-tagged HALT-1 (2.5 µg); lane 3, the pool of “light” and “heavy” 
labelled eluates in which “heavy” labelled lysate has been incubated with GST-tagged (N-
terminus) HALT-1; lane 4, the pool of “light” and “heavy” labelled eluates in which “light” 
labelled lysate has been incubated with GST-tagged (N-terminus) HALT-1. The expected size 
of GST-tagged HALT-1 was approximately 45.8 kDa. 
 
 
 
 
